STOCK TITAN

Helus Pharma: OrbiMed Capital reports 1.2% stake

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Helus Pharma Inc. (HELP) is the issuer whose shares OrbiMed Advisors LLC and OrbiMed Capital LLC reported beneficially owning; September 30, 2026 is listed as the event date. OrbiMed Advisors reported 496,265 shares (0.7%), while OrbiMed Capital reported 847,910 shares (1.2%).

The two entities also stated that, on behalf of other persons, they hold 1.8% of the shares of Common Stock issuable upon exercise of warrants.

Beneficial ownership — OrbiMed Advisors LLC 496,265 shares 0.7% of the class; event date September 30, 2026
Beneficial ownership — OrbiMed Capital LLC 847,910 shares 1.2% of the class; event date September 30, 2026
Warrant-issuable Common Stock held on behalf of others 1.8% Reported by OrbiMed Advisors LLC and OrbiMed Capital LLC in the aggregate
beneficial ownership regulatory
"Aggregate Amount Beneficially Owned by Each Reporting Person"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
Shared Voting Power regulatory
"Shared Voting Power 496,265.00"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.
Sole Dispositive Power regulatory
"Sole Dispositive Power 847,910.00"
Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.
shares of Common Stock issuable upon the exercise of warrants financial
"shares of Common Stock issuable upon the exercise of warrants"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many HELP shares did OrbiMed Advisors and OrbiMed Capital report owning?

OrbiMed Advisors LLC reported beneficial ownership of 496,265 shares (0.7%), and OrbiMed Capital LLC reported 847,910 shares (1.2%). The event date is September 30, 2026.

Who had voting and dispositive power over the HELP shares reported by OrbiMed?

OrbiMed Advisors LLC reported shared voting and dispositive power over its 496,265 shares. OrbiMed Capital LLC reported sole voting and dispositive power over its 847,910 shares.

Who exercised power over the warrant-issuable HELP shares reported by OrbiMed?

The entities said a management committee comprising Carl L. Gordon, W. Carter Neild and Geoffrey C. Hsu exercises investment and voting power over the shares issuable upon warrant exercise. Each committee member disclaims beneficial ownership of those shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





423492107

(CUSIP Number)
09/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



ORBIMED ADVISORS LLC
Signature:/s/ Carl L. Gordon
Name/Title:Carl L. Gordon/Member
Date:11/16/2026
ORBIMED CAPITAL LLC
Signature:/s/ Carl L. Gordon
Name/Title:Carl L. Gordon/Member
Date:11/16/2026

Keep reading